Gamma Knife Radiosurgery Gets Nod in Guinness World Records 2012 Edition for Halting Growth of “World’s Tallest Living Human”

ATLANTA, March 16 /PRNewswire/ – Sultan Kosen won’t be posting new world records for height anymore, but that’s just fine with him. The Gamma Knife® radiosurgery the 29-year-old Turkish man had in August 2010 has successfully stopped his growth at the height of 8 ft 3 in (251 cm). Mr. Kosen, who suffered the effects of acromegaly, has held the title of “World’s Tallest Living Human” since September 2009, when his 8 ft plus stature edged 7 ft 9 in Xiu Xung from China.

In an item in the Guinness World Records 2012 Edition (page 84, U.S./U.K. versions), Guinness World Record recognized Mr. Kosen’s Gamma Knife surgery by Dr. Jason Sheehan at the University of Virginia for finally putting a stop to the man’s height gains, which were causing a host of health problems.

For 18 years, beginning at age 10, a tumor in Mr. Kosen’s brain secreted enormous amounts of growth hormone. Gamma Knife radiosurgery was seen as the technique that offered the best chance of improving his acromegaly.

Leksell Gamma Knife radiosurgery, a gentler alternative to traditional brain surgery, delivers 192 low-intensity radiation beams to one or more targets and with pinpoint accuracy – in this case, Mr. Kosen’s tumor.

Read more at: http://tinyurl.com/7dqqs95.

# # #

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European Time

Michelle Lee Joiner, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.joiner@elekta.com
Time zone: ET: Eastern Time

 
About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

Tags:

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links